Top

BMC Musculoskeletal Disorders

Published in:

Open Access 01-12-2015 | Case report

Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases

Authors: Elia Valls Pascual, Lucía Martínez-Costa, Fernando Santander

Published in: BMC Musculoskeletal Disorders | Issue 1/2015

Abstract

Background

Central serous chorioretinopathy is a disorder often related to systemic corticosteroids, drugs commonly used in rheumatologists’ clinical practice. Central serous chorioretinopathy prognosis is generally good but in some cases, it may lead to substantial loss of vision resulting in an important functional limitation for patients.

It is very important to distinguish this pathology from other diseases involving retinal detachment. When central serous chorioretinopathy and uveitis coexist, it is mandatory to distinguish serous retinal detachment from a uveitis worsening, as the respective treatments can be radically different.

Case presentation

We describe three cases of central serous chorioretinopathy in patients taking systemic corticosteroids due to rheumatological diseases (ankylosing spondylitis, systemic lupus erythematosus and Behçet’s disease). They were diagnosed and managed at our Multidisciplinary (Rheumatology-Ophthalmology) Uveitis Clinic. All three cases improved after corticosteroids dose tapering.

Conclusion

Central serous chorioretinopathy must be kept in mind by rheumatologists as it is related to systemic corticosteroids.

Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina. 1987;7:111–31.CrossRefPubMed

Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry. 1987;144:46–50.CrossRefPubMed

Errera MH, Kohly RP, da Cruz L. Pregnancy-associted retinal diseases and their management. Surv Ophthalmol. 2013;58:127–42.CrossRefPubMed

Farzan K, Rezaei L, Ghanbari H, Dehghani A. Central serous chorioretinopathy following kidney transplantation. Saudi J Kidney Dis Transpl. 2014;25(3):615–20.CrossRefPubMed

Tsai DC, Chen SJ, Huang CC, Chou P, Chung CM, Chan WL, et al. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan. Retina. 2014;34(9):1867–74.CrossRefPubMed

Stefaniotou M, Vourda E, Katsanos A, Aspiotis M. Multifocal 218 central serous chorioretinopathy associated with steroids in a patient with myasthenia gravis. Case Rep Ophthalmol. 2013;4(2):1–6.CrossRefPubMedPubMedCentral

Grixti A, Kumar V. Steroid induced central serous chorioretinopathy in giant cell arteritis. Case Rep Ophthalmol Med. 2013;2013:924037.PubMedPubMedCentral

Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case–control study. Graefes Arch Clin Exp Ophthalmol. 2004;242(9):800–2.CrossRefPubMed

Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47(5):431–48.CrossRefPubMed

10.

Thoelen AM, Bernasconi PP, Schmid C, Messmer EP. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina. 2000;20:98–9.CrossRefPubMed

11.

Hannouche D1, Korobelnik JF, Cochereau I, Hayem G, Beaudreuil J, Meyer O, et al. Systemic lupus erythematosus with choroidopathy and serous retinal detachment. Int Ophtalmol. 1995;19(2):125–7.

12.

Matsuo T, Nakayama T, Koyama T, Matsuo N. Multifocal pigment epitelial damages with serous retinal detachment in systemic lupus erythematosus. Ophtalmologica. 1987;195(2):97–102.CrossRef

13.

Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86:126–45.CrossRefPubMed

14.

Khairallah M, Kahloun R, Tugal-Tutkun I. Central serous chorioretinopathy, corticosteroids, and uveitis. Ocul Immunol Inflamm. 2012;20(2):76–85.CrossRefPubMed

15.

Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous 241 chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58(2):103–26.CrossRefPubMedPubMedCentral

Title: Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases
Authors: Elia Valls Pascual
Lucía Martínez-Costa
Fernando Santander
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Musculoskeletal Disorders / Issue 1/2015
Electronic ISSN: 1471-2474
DOI: https://doi.org/10.1186/s12891-015-0843-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases

Abstract

Background

Case presentation

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2015

Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis

Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)

T1ρ magnetic resonance imaging quantification of early articular cartilage degeneration in a rabbit model

Rivaroxaban does not impair fracture healing in a rat femur fracture model: an experimental study

A randomised trial into the effect of an isolated hip abductor strengthening programme and a functional motor control programme on knee kinematics and hip muscle strength

Ilizarov bone transport for the treatment of fibular osteomyelitis: a report of five cases